---
category: listing
circular_id: 3068b925a8f245fa
date: '2025-11-18'
description: Thyrocare Technologies Limited announces bonus issue at 2:1 ratio with
  deemed allotment date December 1, 2025 and trading commencement December 2, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={9140D783-9534-4E34-9F8F-C533A7171624}&noticeno=20251118-44&dt=11/18/2025&icount=44&totcount=60&flag=0
impact: high
impact_ranking: high
importance_ranking: high
justification: Corporate action with 2:1 bonus ratio affecting 10.61 crore shares,
  significant for existing shareholders and market capitalization adjustment
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251118-44&attachedId=ec5af124-0aee-4081-a5a4-f6c74ba9e380
processing:
  attempts: 1
  content_hash: 54ca476842679553
  processed_at: '2025-11-19T01:38:45.819606'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-11-18T13:18:32+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={9140D783-9534-4E34-9F8F-C533A7171624}&noticeno=20251118-44&dt=11/18/2025&icount=44&totcount=60&flag=0
severity: medium
source: bse
stocks:
- THYROCARE
tags:
- bonus-issue
- equity-shares
- allotment
- corporate-action
- thyrocare
title: Bonus Issue of Thyrocare Technologies Limited - 2:1 Ratio
---

## Summary

Thyrocare Technologies Limited (Scrip Code: 539871) has submitted details of its bonus issue to BSE, confirming issuance of 10,61,07,794 equity shares at a 2:1 ratio. The deemed date of allotment is December 1, 2025, with shares to be credited to deposition systems by 12:00 PM on the same day. Trading of bonus shares will commence on December 2, 2025. The company has obtained in-principle approval from BSE and complied with SEBI Circular SEBI/CIR/CFD/PoD/2024/122.

## Key Points

- Bonus ratio: 2:1 (2 bonus shares for every 1 existing share)
- Total bonus shares to be issued: 10,61,07,794 equity shares
- Face value: ₹10 per share
- Deemed date of allotment: December 1, 2025 (T+1 day)
- Effective listing date: December 2, 2025 (T+2 day)
- Distinctive number range: 54012798 to 160120591
- ISIN: INE594H01019
- Record date intimation filed: November 16, 2025
- In-principle approval from BSE obtained
- Scrutinizer's report uploaded 3 working days before record date

## Regulatory Changes

No regulatory changes announced. The circular confirms compliance with SEBI Circular SEBI/CIR/CFD/PoD/2024/122 dated September 16, 2024, regarding timelines for bonus share credit and trading availability.

## Compliance Requirements

- Company undertakes to credit bonus shares to depository system by 12:00 PM on December 1, 2025 (T+1 day)
- Bonus equity shares must be available for trading at Beginning of Day (BOD) on December 2, 2025 (T+2 day)
- In-principle approval from BSE obtained as required
- Scrutinizer's report uploaded on BSE Listing Centre 3 working days before record date
- Compliance with SEBI circular timelines mandatory

## Important Dates

- **November 16, 2025**: Record date intimation filed
- **November 17, 2025**: Bonus issue details and undertaking submitted to BSE
- **December 1, 2025**: Deemed date of allotment (T+1 day), bonus shares to be credited by 12:00 PM
- **December 2, 2025**: Effective listing date and trading commencement (T+2 day)

## Impact Assessment

**Shareholder Impact**: Existing shareholders will receive 2 bonus shares for every 1 share held as on the record date, tripling their shareholding without additional investment. The face value per share remains ₹10.

**Market Impact**: The issuance of 10.61 crore bonus shares will triple the issued share capital. While the total market capitalization remains unchanged, the per-share price will adjust proportionately downward, improving liquidity and accessibility for retail investors.

**Trading Impact**: Shares will be available for trading from December 2, 2025. Investors should expect price adjustment to reflect the 2:1 bonus ratio. The increased float may enhance trading volumes and market depth for Thyrocare Technologies Limited stock.